Left ventricular assist device malfunction: a systematic approach to diagnosis  by Horton, Steven C. et al.
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OBJECTIVES A protocol was designed to diagnose the common malfunctions of a left ventricular assist
device (LVAD).
BACKGROUND Mechanical circulatory support, primarily with an LVAD, is increasingly used for treatment
of advanced heart failure (HF). Left ventricular assist device dysfunction is a recognized
complication; but heretofore, a systematic method to accurately diagnose LVAD dysfunction
has not been thoroughly described.
METHODS We developed a catheter-based protocol designed to characterize a normally functioning
LVAD and diagnose multiple types of dysfunction. A total of 15 studies of 10 patients
supported with an LVAD were reviewed. All patients had been evaluated due to concerns
regarding LVAD dysfunction.
RESULTS Of 15 examinations performed, 11 documented severe LVAD inflow valve regurgitation. One
of these cases proved to have coexistent severe mitral valve regurgitation. One case was
diagnosed with distortion of the LVAD outflow graft. One case of suspected embolization
from the pumping chamber excluded the outflow graft as the source of emboli. One study had
aortic insufficiency.
CONCLUSIONS As LVAD use for treatment of end-stage HF becomes widespread and durations of support
are extended, dysfunction will be increasingly prevalent. This catheter-based protocol
provided a practical method to diagnose multiple causes of LVAD dysfunction. (J Am Coll
Cardiol 2004;43:1574–83) © 2004 by the American College of Cardiology Foundationp
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techanical circulatory support, primarily with a left ven-
ricular assist device (LVAD), is increasingly used to treat
dvanced heart failure (HF). Short-term LVADs are highly
uccessful in bridging patients with end-stage HF to trans-
lantation (1,2). Additionally, the Randomized Evaluation
f Mechanical Assistance for the Treatment of Congestive
eart Failure (REMATCH) trial showed that patients
ith New York Heart Association functional class IV
ongestive HF, who were ineligible for heart transplanta-
ion, received a longer-term survival benefit from the
VAD than from optimal medical therapy (3). Thus,
VAD technology has also been proven to be effective for
ong-term HF treatment, frequently referred to as “destina-
ion therapy.” Given the substantial number of patients with
nd-stage HF, as well as the potential benefits offered by
echanical circulatory support, it seems likely that LVAD
se will become a more widespread, mainstream treatment.
As LVAD use becomes more commonplace, the care of
VAD patients will gradually shift away from surgeons
oward cardiologists. This follows the pattern that emerged
s heart transplantation became widely accepted and as
urgical complications were minimized. While the initial
urgery remains under the proper purview of surgeons, ever
ore cardiologists are asked to manage patients who have
VADs. These cardiologists and others who treat these
From the *Division of Utah Artificial Heart Program; †Department of Cardiology,
DS Hospital; and the ‡University of Utah School of Medicine, Salt Lake City,
tah.
Manuscript received April 10, 2003; revised manuscript received November 18,J003, accepted November 24, 2003.atients must, therefore, also deal with the inherent risks in
VAD use, sometimes complications beyond their imme-
iate expertise. One primary concern is LVAD device
ailure, the second leading cause of death in the RE-
ATCH study (3).
We sought to better understand the normal physiology of
VADs, troubleshoot dysfunctional devices, and diagnose
he most common modes of dysfunction. To date, only a
ew catheter-based case reports have been published (4,5).
sing a systematized approach based on cardiac catheter-
zation, we evaluated patients with the HeartMate LVAD
Thoratec Corp., Pleasanton, California), used either as
ridge to transplant or as destination therapy. The protocol
e developed helped characterize a normally functioning
VAD and diagnosed multiple types of dysfunction, in-
luding LVAD inflow valve regurgitation (IVR), outflow
raft distortion, aortic insufficiency, and possible sources of
evice-associated embolization. The protocol offers a useful
ool for cardiologists and others in managing LVAD pa-
ients.
ETHODS
ur pool of patients were all those who had received the
eartMate VE or XVE LVAD since September 1999.
emographic details of those studied are summarized Table
. Of these, six had received the LVAD as a bridge to
ransplant; four had received the LVAD as destination
herapy. All evaluations occurred between June 2000 and
uly 2002.
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May 5, 2004:1574–83 Diagnosis of LVAD DysfunctionOverall, 15 studies using 10 patients on HeartMate
VADs were reviewed. All patients were evaluated for
uspected LVAD dysfunction. The function of each LVAD
as tested according to our catheterization laboratory pro-
ocol for assessing LVAD function, combining catheteriza-
ion data with angiography. The protocol is summarized in
able 2.
All patients were simultaneously evaluated by echocardi-
graphy (6).
tatistical methods. Evaluation of patient differences for
ardiac output, LVAD flow, and related factors are pre-
ented for patients with and without IVR. Values are
resented as means with standard deviation, and Student t
est was used to evaluate the significance of differences
etween inflow valve groups, with two-tailed p values and
.05 considered nominally significant.
ESULTS
fter compiling the assessments, we were able to define a
ormally functioning LVAD, depicted in Figure 1. Any
ormally functioning LVAD in the auto mode (rate auto-
atically adapted by the device according to the blood
olume available) has all of the following seven character-
stics:
) Pulmonary capillary wedge pressure (PCWP) is normal.
The right heart pressures reflect a well-decompressed left
Abbreviations and Acronyms
HF  heart failure
IVR  inflow valve regurgitation
LV  left ventricle/ventricular
LVAD  left ventricular assist device
PCWP  pulmonary capillary wedge pressure
REMATCH  Randomized Evaluation of Mechanical
Assistance for the Treatment of
Congestive Heart Failure
able 1. Patient Demographics
No. Age Gender Etiology Indication for Study
Da
I
1 22 M IDCM Hemolysis
2 51 M ICM Runaway VAD
3 78 M ICM Runaway VAD
3 78 M ICM Pump failure
4 57 M ICM Runaway VAD
4 57 M ICM Pump failure
5 63 M ICM Pump failure
5 63 M ICM Embolization
6 30 F IDCM Runaway VAD
7 36 F IDCM Runaway VAD
7 36 F IDCM Runaway VAD
8 48 M ICM Runaway VAD
9 65 F ICM Runaway VAD
0 64 M ICM Runaway VAD
0 64 M ICM Pump failure
CM  ischemic cardiomyopathy; IDCM  idiopathic dilated cardiomyopathy; IV 
entricular assist device.ventricle (LV). For the PCWP to be considered normal,
it must be normal in the auto mode or, after being
converted from the “fixed-rate” mode, the PCWP must
normalize within 5 min after conversion.
) Cardiac output as indicated in the LVAD monitor is
approximately the same as the thermodilution-derived
cardiac output as long as no native LV ejection is
occurring through the aortic valve.
) Aortic blood tracings do not display any significant
beat-to-beat variability. In the absence of a native LV
contribution, aortic pressure is purely mechanical. It
should, therefore, be “clockwork regular.”
) There is no pressure gradient within the LVAD outflow
graft; there is no significant systolic gradient across the
LVAD outflow valve. These correspond to the pressures
measured in condition 2, 3, 4, and 5 checked in the
catheterization laboratory protocol (Table 2).
) The outflow graft appears smooth without distortion
(Fig. 2).
) There is no regurgitation of the LVAD outflow valve on
angiography.
) Left ventricular pressures typically remain less than
aortic pressures. The LV pressures vary related to their
timing with the LVAD cardiac cycle. Hemodynamic
parameters from a normal study are shown in Table 3.
sing this definition of normal function as a baseline, we
ought to diagnose several types of LVAD dysfunction:
VAD IVR, outflow graft distortion, embolization from
VAD pumping chamber, and acquired aortic valve disease.
ur findings with respect to each type of malfunction are
iscussed in detail in the following text.
VAD inflow valve regurgitation. Inflow valve regurgita-
ion causes ineffective decompression of the LV, and a
olume overloaded state, which eventually renders the
VAD unable to completely decompress the LV. Inflow
alve regurgitation can be caused by a torn cusp or commi-
ure dehiscence of the prosthetic valve. This can be the
om
nt Findings at Study Documentation
Kink in the outflow graft Surgery, kink in the outflow graft
IVR, severe IV deformation @ explantation
IVR, mod-severe Not obtained
IVR, severe IV deformation @ explantation
IVR, mod-severe Not obtained
IVR, severe IV deformation @ explantation
Normal angio study Not obtained
Normal angio study Normal valves
IVR, mod-severe IV deformation @ explantation
IVR, mod-severe Not obtained
IVR, mod-severe IV deformation @ explantation
IVR, minimal IV deformation @ explantation
IVR, mod-severe IV deformation @ explantation
IVR, mild-mod Not obtained
IVR, mod-severe IV deformation @ explantation
w valve; IVR  left ventricular assist device inflow valve regurgitation; VAD  leftys Fr
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Diagnosis of LVAD Dysfunction May 5, 2004:1574–83esult of high pump chamber pressure. Conditions that can
ore rapidly lead to this IVR include significant hyperten-
ion and outflow graft twisting or distortion (7).
Clinically, these patients typically presented with pro-
onged, excessively fast LVAD rates (115 to 120 beats/min)
hen placed in the auto mode. This produces the condition
olloquially known as “runaway VAD.” Of 31 VE-LVAD
able 2. Catheterization Laboratory Protocol for Assessing LVA
rior to Procedure
1. The hand pump should be readily available throughout the test.
2. Prep the field allowing for easy access to the driveline without breakin
3. VE system monitor is needed for comparing LVAD flows with simul
4. Pneumatic pumping (IP) is used for the remainder of the test. IP low
5. TURN OFF ICDs: ICDs will be triggered by electrical artifact occur
6. Catheters: 7-F arterial sheaths, 6-F angled pigtail catheter, 6-F multi
guidewire and 0.034-inch exchange-length guidewire.
rocedure
1. Place a Swan-Ganz catheter and measure pressures in the standard m
cardiac output initially in fixed mode, followed by 5 min later in “au
Normally, due to contribution of native heart contraction, Swan-Gan
than 20% are considered significant.
2. Change from electrical to IP for the subsequent portions of the test. R
about 40 to 50 cardiac cycles for conditions 4 to 10.
3. Place a 6-F angled pigtail catheter into the ascending aorta. Measure sim
4. Enter the efferent limb of the outflow graft at 30° LAO. The efferent
5. Advance the catheter down the graft until it is quite near the outflow
6. Inject 30 cc of contrast (14 cc/s) in 10° LAO position @ 30 frames/s.
to assess valvular regurgitation.
7. Inject 30 cc of contrast (14 cc/s) in 10° LAO position @ 30 frames/s.
with the aorta and on the ascending aorta. Aortic insufficiency can u
8. Advance the pigtail catheter across the outflow valve. Record conditio
9. Advance the pigtail catheter across the aortic valve. Record conditions
0. Exchange the pigtail catheter for a built-purpose catheter and advance
multi-purpose catheter into the conduit. If so, using an exchange wir
the conduit can be more easily entered. To perform angiography, exc
catheter. The proximal holes will inject dye proximal to the inflow v
1. Inject 40 cc of contrast (14 cc/s) in 40° LAO @ 30 frames/s. Panning
2. Record condition 11 as the multi-purpose catheter is withdrawn back
onditions
1. Femoral artery  ascending aorta. The two pressures should be very c
vascular disease or a need to rebalance transducers.
2. Femoral artery  distal outflow graft. A systolic increase of 10 mm H
3. Femoral artery  proximal outflow graft (close to outflow valve). Thi
stenosis. A systolic gradient of 10 mm Hg indicates an abnormalit
4. Femoral artery  LVAD outflow (pigtail across outflow valve). A sys
5. Pigtail pullback (record pressure across outflow valve). This is a confir
6. Femoral artery  LV (record LV pressure). LV pressures reflect the s
7. LV  PA (record LV and PA pressure).
8. LV  PCW position (record LV and PCW pressure). Assesses the in
stenosis.
9. Femoral artery  LVAD inflow near inflow valve.
0. Femoral artery  LVAD inflow conduit across the inflow valve. Pressure
1. Femoral artery  pigtail pullback (record pressure across inflow valve)
CD  implantable cardiac defibrillators; IP  pneumatic driver; LAO  left anteri
pulmonary artery; PCW  pulmonary capillary wedge; RCA  right coronary aratients implanted between 1999 and 2001, we diagnosed w1 with significant IVR (32%). The average time from
mplantation to first onset was six months. The earliest
nset was 2 months after implantation; the latest onset was
5 months after surgery.
Of our 15 angiographic examinations, 11 were diagnosed
ith severe IVR. One experienced coexistent severe mitral
alve regurgitation. At angiography, the LV became opaque
nction
sterile field.
us thermodilution cardiac outputs.
e risk of catheter entrapment.
hen guidewires are placed in the inflow cannula.
se catheter, Swan-Ganz type balloon-tipped catheter, 0.034-inch
. Obtain cardiac outputs by thermodilution or Fick Method. Measure
ode. Record simultaneous LVAD flows from the VE system monitor.
heter reading is slightly higher than pump output. Discrepancies higher
d pressures and wave forms in each condition. It is important to record
ous ascending aortic and femoral artery pressures. Record condition 1.
attaches to the aorta just above the RCA. Record condition 2.
. Record condition 3.
rded images should view the outflow valve and the conduit beneath it
rded images should concentrate on the outflow graft, its anastamosis
be seen during the latter portion of this angiogram, if it is present.
and 5.
8, and 9.
catheter across the inflow valve. It is usually difficult to directly place a
ce a Swan-Ganz catheter into the LV, and with the balloon inflated,
e over-the-wire for the multi-purpose catheter. Do not use a pigtail
ecord condition 10.
ld be toward the LV to assess inflow valve regurgitation.
the LV.
o the same. Discrepancies typically indicate the presence of peripheral
uld suggest a narrowing of the anastamosis.
ition is to check the efferent limb (outflow graft) for severe bends or
radient indicates stenosis of the outflow valve.
ry measurement to assess outflow graft stenosis.
f decompression and should rarely reach femoral artery systolic pressure.
ty of the mitral valve for the presence of mitral regurgitation and mitral
measured before angiography. These should be identical to condition 4.
que coronary artery; LV  left ventricle; LVAD  left ventricular assist device; PA
E  vented electric.D Fu
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May 5, 2004:1574–83 Diagnosis of LVAD Dysfunctionnjection into the LVAD beyond the inflow valve. This
orrelated well with observations made simultaneously with
cho-Doppler studies (8). Hemodynamically, patients with
VR differed from normal in the following ways:
) Right heart pressures reflect a non-decompressed LV.
The PCWP is elevated in the fixed mode and rarely
returns to normal in the auto mode. This is observed
upon insertion of the thermodilution catheter and in
conditions 7 and 8 of our protocol.
) The actual cardiac output, as measured by thermodilu-
tion or Fick methods, is significantly less than those
displayed on the LVAD system monitor, indicative of
the degree of ineffective cycling of blood.
) The LVAD rate accelerates and remains at maximal
rates in the auto mode.
) Aortic blood pressures may vary significantly over many
consecutive beats and follow a periodic pattern. Exam-
ples of this variability are shown in Figure 3.
) Simultaneous LV and aortic pressure tracings reveal
elevated aortic pressures when left ventricular systole and
LVAD systole occur synchronously. When the systoles
occur non-synchronously, the aortic pressures are de-
creased (Figs. 3 and 4).
igure 1. Normal HeartMate left ventricular assist device (LVAD) phys-
ology. The Thoratec HeartMate LVAD commences support at the left
entricular apex where a cannula allows blood to flow across a 25-mm
edtronic pig valve into the LVAD pumping chamber. An electric motor
oves a cam 360°, which engages and raises a pusher plate. This movement
jects a systolic volume of 80 cc. Blood is ejected across a second 25-mm
edtronic pig valve through an outflow graft that has an anastamosis in
he proximal ascending aorta. Synchronous pumping means LVAD systole
ccurs simultaneously with native left ventricular systole. Asynchronous
umping indicates the LVAD ejects during native left ventricular diastole.
able 3. An Example of a Normal Study
ode Ao RA PA PCW
CO
(Thermodilut
ixed 100/70 10 50/25 25 6.1 l/min
uto 100/70 8 35/16 15 7.2 l/mino  aorta; CO  cardiac output; LVAD  left ventricular assist device; PA  pulmona) Because of the regurgitant volume, LV diastolic pres-
sures (IVR wave) are more elevated during asynchronous
periods of LVAD pumping. Figure 4 illustrates this
wave pattern.
) Angiography reveals regurgitation of radiocontrast dye
into the LV with injection beyond the LVAD inflow
valve.
) In patients with coexistent mitral regurgitation, signifi-
cant v waves are present in the PCWP tracing.
igure 5A illustrates the LV opacification and the hemo-
ynamic data (Fig. 5B) of a typical case of IVR. Figure 5C
hows the appearance of the inflow valve at the time of
urgical removal.
In patients without IVR, cardiac output exceeded LVAD
ow by an average of 11% (range, 0% to 11.4%). In patients
ith LVAD IVR, the mean LVAD flow was, on average,
2.6% higher (range, 16.3% to 38.9%). When compared with
atients without IVR, patients with IVR showed significantly
ower cardiac output, higher LVAD flows and rates, and a
reater difference between cardiac output and pump flow (p
.001). This data is summarized in Table 4.
Two other conditions that could lead to discrepancies
etween measured cardiac output and LVAD flow rates are
Figure 2. Angiography of the outflow graft.
LVAD Flow
(l/min)
Heart Rate
(ECG)
LVAD
Rate
Stroke
Volume
5.6 l/min 100 beats/min 70 beats/min 80 cc
7.2 l/min 100 beats/min 100 beats/min 80 ccion)ry artery; PCW  pulmonary capillary wedge; RA  right atrial pressure.
F
r
F
a
L
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Diagnosis of LVAD Dysfunction May 5, 2004:1574–83igure 3. Aortic blood pressure variability with simultaneous left ventricle (LV) tracing in a patient with left ventricular assist device (LVAD) inflow valve
egurgitation. ART  arterial pressure.igure 4. Inflow valve regurgitation (IVR) waveforms. Pressure tracing taken from the left ventricle (LV) in the presence of severe IVR during periods of
synchronous and synchronous pumping. Arrows indicate IVR waves associated with regurgitation from the left ventricular assist device (LVAD) into the
V when the LVAD ejects. Other abbreviations same as in Figure 3.
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May 5, 2004:1574–83 Diagnosis of LVAD Dysfunctionortic insufficiency and LVAD outflow valve insufficiency.
e did not detect any cases with these problems.
This protocol was not designed for detection of inflow
alve obstructions that could occur in the setting of hyper-
rophic cardiomyopathy, vegetations, or other impinge-
ents of the inflow cannula. Detection of that would
equire introduction of two pressure catheters, one in the
V and one in the body of the LVAD, with simultaneous
ressure measurements.
utflow graft distortion. One of our patients was diag-
osed with distortion of the LVAD outflow graft resulting
rom LVAD displacement in a morbidly obese patient.
linically, this patient presented with hemolytic anemia.
is alarms indicated his LVAD was pumping against high
ressures. Systolic pressure obtained within the LVAD
umping chamber (condition 10) was 324 mm Hg. At
ngiography, the outflow graft demonstrated an acute angle
end, making it impossible for a guide wire to pass beyond
igure 5. Examples of inflow valve regurgitation. (A) Left ventricular opac
lectrocardiogram; LVAD  left ventricular assist device; PA  pulmona
ppearance of inflow valve at time of surgery.
Table 4. Comparison of CO and LVAD Flow
Are in Auto Mode)
Mean
(SD)
CO
(l/min)
LVA
(l
Without IVR 5.7  1.4 5.1
With IVR 4.5  1.1 6.7CO  cardiac output; IVR  inflow valve regurgitation; LVAD he kinked graft. This distortion was confirmed at the time
f surgery.
Figure 6A shows condition 10 pressures, and a still frame
f how the graft appeared at angiography (Fig. 6B).
VAD-associated thrombembolization. One of our pa-
ients was diagnosed with embolization from the pumping
hamber of a failed LVAD as a diagnosis of exclusion. He
resented with acute bilateral leg pain. Angiography revealed a
lot at the aortoiliac bifurcation. Because angiography of the
utflow graft excluded the graft as the source of the thrombus,
e were able to choose an abdominal approach to replace only
he LVAD pump. After explant, we confirmed that a throm-
us was within the LVAD chamber. On review, this patient
ad been exposed, without anticoagulation, to a long period of
ub-optimal flow dynamics with inadequate filling and emp-
ying while his LVAD was activated pneumatically.
cquired aortic valve disease. Both acquired aortic steno-
is and insufficiency are known to develop during LVAD
ion. (B) Hemodynamic data. Ao  aorta; CO  cardiac output; ECG 
ery; PCW  pulmonary capillary wedge; RA  right atrial pressure. (C)
Normal and IVR Patients (LVAD Patients
ow LVAD Rate
(beats/min)
Flow Minus
CO (l/min)
1 66  14 0.7  0.8
9 90  13 2.2  1.5ificat
ry arts in
D Fl
/min)
 1.
 0.left ventricular assist device.
F
a
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Diagnosis of LVAD Dysfunction May 5, 2004:1574–83igure 6. Examples of a kinked outflow graft. (A) High pressures measured within the left ventricular assist device pumping chamber, with simultaneous
ortic pressures. (B) Angiographic appearance.
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May 5, 2004:1574–83 Diagnosis of LVAD Dysfunctionherapy (9,10). One of our patients had minimal, asymp-
omatic aortic insufficiency. Angiography performed in
ondition 3 of the protocol offers adequate opacification of
he ascending aorta to test for this condition. If high-grade
ortic stenosis was suspected, then detection would be
mproved by dropping LVAD rates to low levels in order to
dequately detect a gradient, because gradients are directly
roportional to native ventricular outflow across the native
alve. However, detection of aortic stenosis is not usually
linically necessary because an LVAD can function normally
n the setting of aortic stenosis (11). Aortic stenosis would
e very relevant in the setting of LVAD failure, or when the
VAD is used as a bridge to recovery.
omplications. No serious complications occurred using
ur protocol. There were no complications of bleeding,
nfection, vascular trauma, or stroke.
Two patients experienced transient arrhythmias. Most
rrhythmias are tolerated with a well-functioning LVAD.
ne patient developed ventricular fibrillation during cath-
terization. The patient remained hemodynamically stable
n LVAD support and was easily cardioverted back into
ormal sinus rhythm. This arrhythmia is illustrated in
igure 7.
A unique rhythm situation arose when exchange guide
ires were used to place a multi-purpose catheter across the
nflow valve within a VE-LVAD. We believe these guide
ires transmitted a small electrical current that was sensed
Figure 7. Example of normal aortic pressure with left ventricuy the surface electrocardiogram leads. While in normal Rinus rhythm, one patient’s defibrillator interpreted the
therwise benign current as ventricular fibrillation and
ssued defibrillating shocks. The electrocardiograms that
esulted are depicted in Figure 8. To avoid this situation, the
rotocol now calls for defibrillators and pacemakers to be
ppropriately reprogrammed during catheterization.
ISCUSSION
eft ventricular assist device malfunction is an important
ause of morbidity and mortality (3). The incidence of
evice malfunction will increase in the future as durations of
upport exceed the life expectancy of current generation
VADs. As cardiologists provide care for an increasing
umber of LVAD patients, it is particularly important that
hey be able to accurately diagnose and successfully trouble-
hoot a dysfunctional device. This paper presents a catheter-
ased protocol designed to meet that need. By using this
iagnostic tool, cardiologists and others who care for
VAD patients should be able to successfully identify most
alfunctions of the LVAD.
cknowledgments
he authors gratefully appreciate the assistance of Ashley
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Diagnosis of LVAD Dysfunction May 5, 2004:1574–83igure 8. (A) Normal sinus rhythm on entry to the catheterization laboratory. (B) Electrocardiogram with electrical artifact with exchange wire across the
nflow valve.
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